Abstract:In common variable immunodeficiency (CVID), heterozygous damaging NFKB1 variants represent the most frequent monogenic cause. NFKB1 encodes the precursor p105, which undergoes proteasomal processing to generate the mature NF-κB transcription factor subunit p50. The majority of NFKB1 sequence changes comprises missense variants of uncertain significance (VUS), each requiring functional evaluation to assess causality, particularly in families with multiple affected members presenting with different phenotypes. In four affected members of a German family, all diagnosed with CVID, we identified a previously uncharacterized heterozygous NFKB1 missense variant (c.1049A>G; p.Tyr350Cys). The clinical phenotypes varied markedly regarding onset, frequency and severity of infections. Consistent immunologic findings were hypogammaglobulinemia with normal specific antibody response to protein- and polysaccharide-based vaccinations, reduced switched memory B cells and decreased lymphocyte proliferation upon stimulation with the B cell mitogen SAC. To assess the pathogenicity of the NFKB1 missense variant, we employed immunophenotyping and functional analyses in a routine in vitro cell culture model. Following site-directed mutagenesis to introduce the variant into overexpression vectors encoding EGFP-fused p105 or p50, we analyzed transiently transfected HEK293T cells by confocal imaging and Western blotting. The cytoplasmic p105-Tyr350Cys precursor gained only weak expression levels indicating accelerated decay. The missense change disabled processing of the precursor to prevent the generation of mutant p50. Unlike the wildtype p50, the overexpressed mutant p50-Tyr350Cys was also not sustainable and showed a conspicuous subnuclear mislocalization with accumulation in dense aggregates instead of a homogenous distribution. Electrophoretic mobility shift assays, fluorescence-based reporter gene analyses and co-transfection experiments however demonstrated, that the DNA-binding activity of p50-Tyr350Cys and the interaction with RelA(p65), IκBα and wildtype p50 were preserved. Mutation carriers had reduced p105 and p50 levels, indicating insufficient protein amounts as the most likely primary defect. In conclusion, the missense variant c.1049A>G caused a detrimental defect, preventing the persistent expression of both, the p105-Tyr350Cys precursor and the mature p50-Tyr350Cys. The variable clinical phenotypes among affected family members sharing an identical pathogenic NFKB1 variant support a disease mechanism provoked by a p105/p50 (haplo)insufficient condition.

Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID

Common Variable Immunodeficiency with Genetic Defects Identified by Whole Exome Sequencing.

A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage

Detection of a New NFKB1 Frameshift Mutation Associated with Primary Immunodeficiency Diseases

Intrinsic Functional Defects in B Cells of Patients with NFKB2 Mutations

Combined immunodeficiency caused by a novel homozygous NFKB1 mutation

Revealing disease subtypes and heterogeneity in common variable immunodeficiency through transcriptomic analysis

Target genes regulated by CLEC16A intronic region associated with common variable immunodeficiency

Identification of IL2RG and CYBB Mutations in Two Chinese Primary Immunodeficiency Patients by Whole-Exome Sequencing

Expanding the mutational and clinical spectrum of Chinese intellectual disability patients with two novel CTCF variants

Clinical characteristics and identification of novel CNOT1 variants in three unrelated Chinese families with Vissers-Bodmer Syndrome

Role of Skewed X-Chromosome Inactivation in Common Variable Immunodeficiency

Clinical, Immunological, and Genetic Features in Patients with NFKB1 and NFKB2 Mutations: a Systematic Review

Novel hypermorphic variants in IRF2BP2 identified in patients with common variable immunodeficiency and autoimmunity

Identification of Two Novel Mutations in Patients with X-Linked Primary Immunodeficiencies

Genetics and clinical phenotypes in common variable immunodeficiency

Analysis of rare genetic variants in All of Us cohort patients with common variable immunodeficiency

BI29 Mycosis fungoides presenting in a patient with NFKB1 haploinsufficiency-associated common variable immunodeficiency

Understanding the genetic and epigenetic basis of common variable immunodeficiency disorder through omics approaches

Further Delineation of Primary B Cell Immunodeficiency Caused by Novel Variants of the BLNK Gene in Two Chinese Patients.

A Novel de Novo Variant in 5′ UTR of the NIPBL Associated with Cornelia de Lange Syndrome